newsfilter
← Latest News
GlobeNewswire·

FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics

HOUSTON, May 18, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending focused on the development of